Other
Yassin Abdelghaffar Charity Center for Liver Disease and Research
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 4 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Phase 3
1(33.3%)
Phase 4
1(33.3%)
N/A
1(33.3%)
3Total
Phase 3(1)
Phase 4(1)
N/A(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT03446586Unknown
Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)
Role: lead
NCT03743727Phase 4Unknown
Treatment of Egyptian Hepatitis C Genotype 4 Infected Children and Adolescents With Combined Ledipasvir/Sofosbuvir
Role: lead
NCT03080415Phase 3Completed
Treatment of Egyptian Hepatitis C Genotype 4 Infected Children (and Adolescents) With Combined Sofosbuvir & Daclatasvir
Role: lead
NCT02027493Not ApplicableCompleted
Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV
Role: collaborator
All 4 trials loaded